Ann Calby Miller

This profile gathers the share dealings of Ann Calby Miller across 2 companies, led by Inovio Pharmaceuticals, Inc. and Puma Biotechnology, Inc. We count 12 filings; the first trade dates from 21 March 2020 and the latest from 21 May 2025.

Sales make up the whole of the open-market record (1 sale, €121k). Other entries cover 2 share grants and 9 option exercises.

The newest entry dates from 21 May 2025: an option exercise, in Inovio Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.